RNA N<sup>6</sup>-methyladenosine modification in cancers: current status and perspectives.
Deng X, Su R, Weng H, Huang H, Li Z, Chen J. · 2018
Read RNA N<sup>6</sup>-methyladenosine modification in cancers: current status and perspectives. by Deng X, Su R, Weng H, Huang H, Li Z, Chen J. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5951805.txt.
Description
Deng and co-authors review RNA N6-methyladenosine modification in cancers. Their review appeared in Cell Research. This mark, called m6A, is the most common internal change in messenger RNA. Writer enzymes place it, and eraser enzymes can remove it. Reader proteins then decide the fate of marked messages. They can alter stability, splicing, or translation.
When this machinery goes wrong, it can feed cancer, the authors report. It affects how cancers start, grow, and answer drugs. The review covers recent work on these mechanisms across cancer types. It also discusses drugs that might target the faulty machinery. Such treatment is a growing hope in the field.
Catalog record
| CREATOR | Deng X, Su R, Weng H, Huang H, Li Z, Chen J. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |